« Back
Home /
AT13148

AT13148

Manufacturer	TargetMol
Category	Neuroscience Metabolism Diabetes Aging & Neurological Disorders Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Amount	100mg
Item no.	TMO-T2482-100mg
CASRN	1056901-62-2
eClass 6.1	32169090
eClass 9.0	32169090
Available
Bioactivity	AT13148 is an oral, ATP-competitive, multi-AGC kinase inhibitor with IC50 of 38 nM/402 nM/50 nM, 8 nM, 3 nM, and 6 nM/4 nM for Akt1/2/3, p70S6K, PKA, and ROCKI/II, respectively. Phase 1.
MolWt	313, 78
Pathways	Cytoskeletal Signaling; Cell Cycle/Checkpoint; GPCR/G Protein; Metabolism; PI3K/Akt/mTOR signaling; Stem Cells
Receptor	Akt1; Akt2; Akt3; PKA; ROCK1; ROCK2; p70 S6K; RSK1; SGK3

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100mg

available

Delivery expected until 5/23/2024